Yvonne Greenstreet, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 6,799 shares at $323.62 ($2.2M) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Open-market sale of $2.2M ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $323.62 | 200 | $65K | 2.9% |
| 2 | $324.65 | 382 | $124K | 5.6% |
| 3 | $325.63 | 1,098 | $358K | 16.0% |
| 4 | $326.81 | 1,669 | $545K | 24.5% |
| 5 | $327.67 | 1,399 | $458K | 20.6% |
| 6 | $328.71 | 424 |
| $139K |
| 6.3% |
| 7 | $329.71 | 722 | $238K | 10.7% |
| 8 | $330.85 | 346 | $114K | 5.1% |
| 9 | $331.93 | 399 | $132K | 5.9% |
| 10 | $332.64 | 160 | $53K | 2.4% |
| Total | $327.65 avg | 6,799 | $2.2M | 100% |
| Filing → |
| ALNY | SELL | 2026-01-14 | $3.5M | — | Filing → |
| ALNY | SELL | 2025-11-14 | $23.2M | — | Filing → |
| ALNY | SELL | 2025-10-03 | $8.1M | — | Filing → |